Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

387 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
H(2) mediates cardioprotection via involvements of K(ATP) channels and permeability transition pores of mitochondria in dogs.
Yoshida A, Asanuma H, Sasaki H, Sanada S, Yamazaki S, Asano Y, Shinozaki Y, Mori H, Shimouchi A, Sano M, Asakura M, Minamino T, Takashima S, Sugimachi M, Mochizuki N, Kitakaze M. Yoshida A, et al. Among authors: shinozaki y. Cardiovasc Drugs Ther. 2012 Jun;26(3):217-26. doi: 10.1007/s10557-012-6381-5. Cardiovasc Drugs Ther. 2012. PMID: 22527618
Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the phosphatidylinositol-3 kinase-dependent pathway in canine hearts.
Hirata A, Minamino T, Asanuma H, Sanada S, Fujita M, Tsukamoto O, Wakeno M, Myoishi M, Okada K, Koyama H, Komamura K, Takashima S, Shinozaki Y, Mori H, Tomoike H, Hori M, Kitakaze M. Hirata A, et al. Among authors: shinozaki y. Cardiovasc Drugs Ther. 2005 Jan;19(1):33-40. doi: 10.1007/s10557-005-6895-1. Cardiovasc Drugs Ther. 2005. PMID: 15883754
A role of opening of mitochondrial ATP-sensitive potassium channels in the infarct size-limiting effect of ischemic preconditioning via activation of protein kinase C in the canine heart.
Tsukamoto O, Asanuma H, Kim J, Minamino T, Takashima S, Ogai A, Hirata A, Fujita M, Shinozaki Y, Mori H, Tomoike H, Hori M, Kitakaze M. Tsukamoto O, et al. Among authors: shinozaki y. Biochem Biophys Res Commun. 2005 Dec 23;338(3):1460-6. doi: 10.1016/j.bbrc.2005.10.109. Epub 2005 Oct 26. Biochem Biophys Res Commun. 2005. PMID: 16271703
Granulocyte colony-stimulating factor mediates cardioprotection against ischemia/reperfusion injury via phosphatidylinositol-3-kinase/Akt pathway in canine hearts.
Takahama H, Minamino T, Hirata A, Ogai A, Asanuma H, Fujita M, Wakeno M, Tsukamoto O, Okada K, Komamura K, Takashima S, Shinozaki Y, Mori H, Mochizuki N, Kitakaze M. Takahama H, et al. Among authors: shinozaki y. Cardiovasc Drugs Ther. 2006 Jun;20(3):159-65. doi: 10.1007/s10557-006-8285-8. Cardiovasc Drugs Ther. 2006. PMID: 16775664
Novel Synthesized Radical-Containing Nanoparticles Limit Infarct Size Following Ischemia and Reperfusion in Canine Hearts.
Asanuma H, Sanada S, Yoshitomi T, Sasaki H, Takahama H, Ihara M, Takahama H, Shinozaki Y, Mori H, Asakura M, Nakano A, Sugimachi M, Asano Y, Minamino T, Takashima S, Nagasaki Y, Kitakaze M. Asanuma H, et al. Among authors: shinozaki y. Cardiovasc Drugs Ther. 2017 Dec;31(5-6):501-510. doi: 10.1007/s10557-017-6758-6. Cardiovasc Drugs Ther. 2017. PMID: 29101507
Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts.
Asanuma H, Minamino T, Sanada S, Takashima S, Ogita H, Ogai A, Asakura M, Liao Y, Asano Y, Shintani Y, Kim J, Shinozaki Y, Mori H, Node K, Kitamura S, Tomoike H, Hori M, Kitakaze M. Asanuma H, et al. Among authors: shinozaki y. Circulation. 2004 Jun 8;109(22):2773-9. doi: 10.1161/01.CIR.0000130917.12959.04. Epub 2004 May 17. Circulation. 2004. PMID: 15148268
387 results